COVID-19 vaccines: From nasal drops to a redesign, what 2023 could have in store
CBSN
Several vaccine companies say they are expecting breakthroughs as early as this year as they pursue new ways to protect people against SARS-CoV-2, the virus that causes COVID-19.
The Food and Drug Administration is set to convene a panel of its outside vaccine advisers later this month to weigh key issues over the future of COVID-19 vaccines, including when and how to greenlight new boosters and changes to which strain the vaccines target.
Here's a peek at some of what's expected this year for the next generation of COVID-19 vaccines.
More Related News